Potentiation of 1-beta-D-arabinofuranosylcytosine in hepatoma cells by 2'-deoxyadenosine or 2'-deoxyguanosine.
D000241:Adenosine / Q000494:pharmacology; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D003561:Cytarabine / Q000378:metabolism / Q000494:pharmacology*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003839:Deoxyadenosines / Q000494:pharmacology*; D003849:Deoxyguanosine / Q000494:pharmacology*; D004357:Drug Synergism; D007042:Hypoxanthines / Q000494:pharmacology; D008114:Liver Neoplasms, Experimental / Q000503:physiopathology*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D051381:Rats; D013329:Structure-Activity Relationship; D013936:Thymidine / Q000494:pharmacology
D004273:DNA, Neoplasm; D003839:Deoxyadenosines; D007042:Hypoxanthines; D012334:RNA, Neoplasm; D003561:Cytarabine; D003849:Deoxyguanosine; D000241:Adenosine; D013936:Thymidine